CG Oncology
CGON
CGON
142 hedge funds and large institutions have $1.74B invested in CG Oncology in 2025 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 61 increasing their positions, 34 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 140 → 142 (+2)
8% less capital invested
Capital invested by funds: $1.9B → $1.74B (-$160M)
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
Holders
142
Holding in Top 10
10
Calls
$1.15M
Puts
$859K
Top Buyers
| 1 | +$33.3M | |
| 2 | +$25.5M | |
| 3 | +$23.5M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$16.9M |
| 5 |
Millennium Management
New York
|
+$8.5M |
Top Sellers
| 1 | -$20.1M | |
| 2 | -$12M | |
| 3 | -$5.74M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.68M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$5.49M |
